CDKN2A and cancer: Focusing on p16-negative cases, they showed that a multivariate logistic regression model comprising ITPR3, KMT2D, EMILIN1, and patient’s age can accurately predict second cancer occurrence with 88% sensitivity and 75% specificity [35].